SEP-228432
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SEP-228432, covering 2013-12-09 to 2013-12-09. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1, Open-Label, Single-photon Emission Computed Tomography (SPECT) Study to Evaluate Serotonin and Dopamine Transporter Occupancy After Multiple Dose Administration of SEP-228432 to Achieve Steady State in Healthy Subjects [Phase 1]